ResearchMedicine and treatment
EU backs a pill that nearly doubled survival in metastatic pancreatic cancer
What the European recommendation adds to the US approval, how the updated survival numbers should be read, and what still stands between the decision and patients. Relevant for families facing advanced pancreatic cancer.
4 min read